TCF National Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.56M Sell
13,211
-3,105
-19% -$364K 0.18% 132
2020
Q4
$1.91M Buy
16,316
+614
+4% +$67.6K 0.2% 126
2020
Q3
$1.63M Buy
15,702
+7,785
+98% +$782K 0.19% 128
2020
Q2
$771K Sell
7,917
-4,631
-37% -$444K 0.09% 204
2020
Q1
$1.13M Buy
12,548
+1,635
+15% +$174K 0.17% 141
2019
Q4
$1.24M Buy
10,913
+677
+7% +$74.3K 0.14% 158
2019
Q3
$1.11M Buy
+10,236
New +$1.07M 0.13% 171

Other funds holding MDT

TCF National Bank's MDT Position: Q1 2021 in Review

TCF National Bank reduced its Medtronic (MDT) stake by 19% in Q1 2021, selling an estimated $364K and leaving 13,211 shares worth $1.56M. The position accounts for 0.18% of the portfolio, ranked #132.

TCF National Bank first reported a position in MDT in Q3 2019 and has held it in 7 quarters since. The position peaked at $1.91M in Q4 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • TCF National Bank held 13,211 shares of Medtronic worth $1.56M as of Q1 2021.
  • TCF National Bank sold 3,105 Medtronic shares in Q1 2021, an estimated $364K.
  • Medtronic made up 0.18% of TCF National Bank's portfolio in Q1 2021, its #132 holding.
  • TCF National Bank first reported a position in Medtronic in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Medtronic position peaked at $1.91M in Q4 2020.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.